Mirada Medical raises £6m to develop AI-based medical imaging software to transform cancer treatment

MiradaMedicalLogo

Mirada Medical raises £6m in latest funding round

Portfolio company Mirada Medical has announced a new £6 million investment led by private equity healthcare specialists, Apposite Capital. The investment will support Mirada’s development of artificial intelligence (AI) based software for increasing the speed and accuracy of cancer treatment planning applications, while delivering a more personalised level of care to patients. Apposite has invested alongside Mirada’s founding investor, AlbionVC, and other private investors.

Mirada Medical is a world-leading medical imaging software company, develops medical imaging software applications that provide simple and accessible solutions to complex image analysis problems in the diagnosis and treatment of cancer and other diseases.

You can read more about Mirada Medica, and their recent investment round, on the Mirada Medica website.